News

Fierce Pharma8h
Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer
In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...
Fierce Pharma8h
Meribel makes CDMO debut after series of acquisitions in Europe
For a second time in less than a month, a new CDMO has uncloaked.  | For a second time in less than a month, a new CDMO has ...
Fierce Pharma8h
Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.’s promised drug ad ban: report
The two highest-ranking leaders within the FDA’s Office of Prescription Drug Promotion (OPDP) have stepped down, according to ...
Fierce Pharma9h
Amneal recalls 2 lots of hospital anesthetic over plastic contamination fears
Particulate contamination has sparked the recalls of numerous injectable drugs over the years, with Amneal’s hospital med ...
Fierce Pharma9h
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer
AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line ...
Fierce Pharma10h
Inside Phathom's 'lighthearted' approach to Voquezna marketing, from cheeky tagline to 'SNL' spokes-celeb
When Phathom Pharmaceuticals launched its first direct-to-consumer ads for Voquezn | In a commercial debuting Monday, Kenan ...
Fierce Pharma11h
FDA rejection of extended dosing interval is another piece of bad news for Regeneron’s Eylea HD
The FDA has sent Regeneron a complete response letter, rejecting its bid to stretch the administration of high-dose Eylea ...
Fierce Pharma11h
How Patient Behavior Powers Precision HCP Targeting
Pharma brands spend billions annually trying to engage healthcare providers (HCPs), yet much of this outreach has a limited ...